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Abstract—Tumor necrosis factor (TNF)-alpha is a proinflam-
matory cytokine acting on two distinct receptor subtypes,
namely p55 and p75 receptors. TNF-alpha p55 and p75 recep-
tor knockout mice were previously shown to display a de-
creased or enhanced susceptibility to seizures, respectively,
suggesting intrinsic modifications in neuronal excitability.
We investigated whether alterations in glutamate system
function occur in these naive knockout mice with perturbed
cytokine signaling that could explain their different propen-
sity to develop seizures. Using Western blot analysis of hip-
pocampal homogenates, we found that p55/ mice have
decreased levels of membrane GluR3 and NR1 glutamate
receptor subunits while GluR1, GluR2, GluR6/7 and NR2A/B
were unchanged as compared to wild-type mice. In p75/
mice, GluR2, GluR3, GluR6/7 and NR2A/B glutamate receptor
subunits were increased in the hippocampus while GluR1
and NR1 did not change. Extracellular single-cell recordings
of the electrical activity of hippocampal neurons were carried
out in anesthetized mice by standard electrophysiological
techniques. Microiontophoretic application of glutamate in-
creased the basal firing rate of hippocampal neurons in
p75/ mice versus wild-type mice, and this effect was
blocked by 2-amino-5-phosphopentanoic acid and 6-nitro-7-
sulfamoyl-benzo(f)quinoxaline-2,3-dione denoting the in-
volvement of N-methyl-D-aspartic acid and AMPA receptors.
In p55/ mice, hippocampal neurons responses to gluta-
mate were similar to wild-type mice. Spontaneous glutamate
release measured by in vivo hippocampal microdialysis was
significantly decreased only in p55/ mice. No changes
were observed in KCl-induced glutamate release in both re-
ceptor knockout mice strains versus wild-type mice. These
findings highlight specific molecular and functional interac-
tions between p55 and p75 receptor-mediated signaling and
the glutamate system. These interactions may be relevant for
controlling neuronal excitability in physiological and patho-
logical conditions. © 2009 IBRO. Published by Elsevier Ltd.
All rights reserved.
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Cytokines are critical mediators of specific inflammatory
responses and immune reactions in the CNS (Allan and
Rothwell, 2001). One prototypical proinflammatory cyto-
kine is tumor necrosis factor-alpha (TNF-alpha) that is
expressed at low levels in healthy brain and it is rapidly
upregulated in glia, neurons and endothelial cells in vari-
ous neuropathological conditions such as ischemia, infec-
tion, trauma as well as during seizures (De Simoni et al.,
2000; Sriram and O’Callaghan, 2007; Galic et al., 2008;
Riazi et al., 2008). The biological actions of TNF-alpha are
mediated by two receptor subtypes, namely p55 (TNF-
alpha R1) and p75 (TNF-alpha R2) that are coupled to
distinct, although partially overlapping, intracellular signal-
ing cascades (MacEwan, 2002; Thommesen and Lae-
greid, 2005). Differences in the levels and activation state
of p55 and p75 receptors and related downstream effec-
tors appear to be responsible for the divergent roles of
TNF-alpha in brain (Sriram and O’Callaghan, 2007).
In physiological conditions, a constitutive release of
TNF-alpha from glia has been measured (Stellwagen and
Malenka, 2006; Beattie et al., 2002); p55 and p75 recep-
tors have been described in astrocytes (Kuno et al., 2006)
or neurons cultured in vitro (Pollock et al., 2002) while in
rodent brain TNF-alpha receptors were predominantly ob-
served in neurons and endothelial cells (Nadeau and
Rivest, 1999; Sairanen et al., 2001; Bette et al., 2003;
Balosso et al., 2005). In several disease conditions, up-
regulation of both p55 and p75 receptor subtypes has been
described in glia (Munoz-Fernandez and Fresno, 1998;
Gimenez et al., 2003; Shinoda et al., 2003; Sriram and
O’Callaghan, 2007). The pattern of expression of TNF-
alpha and its receptors in physiological conditions or after
brain injury suggests that this cytokine mediates both au-
tocrine and paracrine effects.
Recent studies have shown that TNF-alpha can regu-
late synaptic transmission (Pickering and O’Connor, 2007;
Viviani et al., 2007). In particular, TNF-alpha released by
glia increases synaptic efficacy by enhancing AMPA re-
ceptors expression on neuronal surface (Beattie et al.,
2002; Leonoudakis et al., 2004; Stellwagen et al., 2005),
and possibly by increasing astrocytic glutamate release
(Bezzi et al., 2001). Moreover, this cytokine has also been
shown to affect synaptic plasticity by inhibiting LTP (Tan-
credi et al., 1992; Cunningham et al., 1996; Butler et al.,
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2004) and by mediating synaptic scaling during activity
blockade (Stellwagen and Malenka, 2006).
TNF-alpha can also contribute to pathological condi-
tions such as neurodegeneration (Ghezzi and Mennini,
2001; Saha and Pahan, 2003; Sriram and O’Callaghan,
2007; Tansey et al., 2007) and seizure activity (Bruce et
al., 1996; Probert et al., 1997; Shandra et al., 2002; Yuhas
et al., 2003; Meli et al., 2004; Balosso et al., 2005; Lu et al.,
2008). In this respect, we demonstrated that injection of
TNF-alpha in the mouse hippocampus exerts anticonvul-
sant effects on kainate seizures by interacting with the
neuronal p75 receptors. Accordingly, mice lacking p75
receptors are more susceptible to seizures (Balosso et al.,
2005). However, in line with different roles of TNF-alpha
receptor subtypes on brain function (MacEwan, 2002;
Sriram and O’Callaghan, 2007), we reported that p55 re-
ceptor knockout mice have a reduced seizure susceptibil-
ity, thus suggesting the existence of an excitatory compo-
nent of the TNF-alpha signaling mediated by p55 receptors
(Balosso et al., 2005).
In view of the established interactions between TNF-
alpha and glutamatergic transmission (see above), we
speculated that the changes in seizure susceptibility in
TNF-alpha receptor knockout mice may involve functional
modifications in the glutamatergic system.
To address this hypothesis, we investigated whether
TNF-alpha p55 and p75 receptor knockout mice show
intrinsic changes in the membrane levels of various
subunits of ionotropic glutamate receptors as well as
modifications in neuronal responses to glutamate, as
assessed in the hippocampus by Western blot and elec-
trophysiology, respectively.
In view of previous evidence that TNF-alpha affects
glutamate release and its glial re-uptake (Chao et al.,
1995; Bezzi et al., 2001; Zou and Crews, 2005; Takeuchi
et al., 2006), we also measured extracellular glutamate
levels in p55 and p75 knockout mice using brain microdi-
alysis.
EXPERIMENTAL PROCEDURES
Experimental animals
TNF receptor knockout male adult mice (60 days old, 25 g) were
obtained by Taconic Farms (New York, NY, USA). Generation of
these mice by using the C57BL6 strain and their detailed charac-
terization were reported previously (Peschon et al., 1998). Age-
matched wild-type C57BL6 were used as controls.
Animals were housed at constant temperature (23 °C) and
relative humidity (60%) with a fixed 12-h light/dark cycle and free
access to food and water.
Procedures involving animals and their care were conducted
in accordance with the ethically approved institutional guidelines
that are in compliance with national and international laws and
policies (EEC Council Directive 86/609, OJ L 358, 1, Dec.12,
1987; Guide for the Care and Use of Laboratory Animals, USA;
National Research Council, 1996). Experiments were carried out
by minimizing the number of mice used and their suffering.
Western blot
Naive p75/, p55/ and wild type mice (n5 each group) were
decapitated, the hippocampi of both hemispheres were dissected
out at 4 °C and the two hippocampi of each brain were pooled.
Tissue was homogenized (30 mg tissue/150 l homogenization
buffer) as previously described (Balosso et al., 2005). An aliquot of
each homogenate (80 l) was centrifuged at 45,000 rpm at 4 °C
for 1 h to separate cytosol and membrane fractions (Bendotti et
al., 2001). Total proteins (70 g per lane; Bio-Rad Protein Assay,
Bio-Rad Laboratories, Munchen, Germany) were separated using
SDS-PAGE 10% acrylamide, and each sample was run in dupli-
cate. Proteins were transferred to Hybond nitrocellulose mem-
branes (Whatman, Dassel, Germany) by electroblotting. For im-
munoblotting, we used an anti-GluR2 (1:750, Chemicon, Te-
mecula, USA) and anti-GluR3 mouse monoclonal antibodies (1:
500, Chemicon), anti-GluR1 (1:1000, Chemicon), anti-GluR6/7
rabbit monoclonal antibodies (1:2000, Chemicon), anti-NR1 (1:
250, Chemicon) and anti-NR2A/B rabbit polyclonal antibodies
(1:750, Chemicon). Immunoreactivity was visualized with en-
hanced chemiluminescence (ECL) using peroxidase-conjugated
goat anti-mouse (1:2000; Sigma) and goat anti-rabbit (1:2000;
Sigma) IgGs as secondary antibodies. Densitometric analysis of
immunoblots was done to quantify the changes in protein levels
(AIS image analyzer, Imaging Research, Inc., Ontario, Canada)
using film exposures with maximal signals below the photographic
saturation point. Optical density values in each sample were nor-
malized using the corresponding amount of neurofilament M (NF;
1:1000, Chemicon) for total homogenate and  tubulin (1:5000;
Sigma, St. Louis, MO, USA) for the membrane fractions.
In vivo microdialysis
Vertical dialysis probes were prepared with a copolymer of acry-
lonitrile-sodium methallyl sulfonate (AN 69, Hospal, SpA, Italy;
0.31 mm outer diameter, with more than 44,000 Da MW cutoff),
essentially as described by Robinson and Whishaw (1988). The
length of the exposed membrane was 2.5 mm p75/, p55/ and
wild type mice (n7–8) were anesthetized with equithesin, placed
on a stereotaxic frame and the dialysis probe was implanted in the
ventral hippocampus. The stereotaxic coordinates were bar nose
0.0; AP 2.6; L 2.6; V 3.4 from bregma and dura surface,
according to Franklin and Paxinos (1997). Twenty-four hours after
surgery, the probes were perfused with artificial cerebrospinal fluid
(aCSF composition in mM: NaCl 140, CaCl2 1.26, KCl 3, MgCl2 1,
Na2HPO4 1.2, glucose 7.2, pH 7.4 with 0.6 M NaH2PO4) at 1
L/min with a CMA/100 pump (CMA/Microdialysis, Stockholm,
Sweden). After a washout period of 90 min, samples of dialysate
were collected every 20 min and stored at 4 °C. A stable glutamate
output was defined as three consecutive baseline samples not
differing by more than 20%, which was followed by 20 min perfu-
sion with 60 mM KCl (prepared as follow in mM: NaCl 87; KCl 60;
CaCl2 1.26; MgCl2 1, in ultrapure water, buffered at pH 7.4 with 2
mM sodium phosphate buffer) to measure depolarization-induced
release of glutamate (Ceglia et al., 2004).
The concentration of glutamate in dialysate samples was
determined by high-performance liquid chromatography with flu-
orometric detection after pre-column derivatization with o-phthal-
aldehyde/-mercaptoethanol (Sigma-Aldrich, Milan, Italy) reagent
according to Donzanti and Yamamoto (1988).
Electrophysiological experiments
Extracellular single unit recording. p75/, p55/ and wild
type mice (n5–8) were anesthetized with chloral hydrate (400
mg/kg i.p.) and mounted on a stereotaxic instrument (SR-6, Nar-
ishige, Japan). Supplemental doses of anesthetic were adminis-
tered intraperitoneally when required. Throughout the experiment,
the animal body temperature was maintained at 36–37 °C by a
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thermostatically regulated heating pad. The coordinates from
bregma for placement of the recording electrode in the hippocam-
pus were posterior 2.0–2.4 mm, lateral 1.6–2.0 mm and ventral
2–2.5 mm (Franklin and Paxinos, 1997). Extracellular recordings
were performed randomly in CA1, CA3 and dentate gyrus in each
experimental group using multi-barrel micropipettes. Four- to six-
barrel homemade micropipettes were pulled to an optimal wide tip
angle and mechanically beveled under microscopic control to a
final tip diameter of 5–8 m. The central barrel, filled with 2 M
NaCl, was used for recording (in vitro resistance 4–7 M) while
one of the side barrels, filled with 2% Pontamine Sky Blue dye in
2 M NaCl, was used for continuous automatic current balancing.
The remaining barrels contained one of the following solutions:
L-quisqualic acid (5 mM, pH 7.5), L-glutamic acid (200 mM, pH 8),
6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione (NBQX) (1 mM,
pH 8), and 2-amino-5-phosphopentanoic acid (AP-5) (50 mM, pH
8). All drugs were from Tocris BioScience and dosages refer to the
salt weight. Unit activity was converted to an integrated histogram
by a rate-averaging computer and displayed as spikes per 10 s
intervals. After each experiment, the recording site was marked by
the ejection of Pontamine Sky Blue dye from the electrode using
a 20 A current for 10 min. Brains were removed and placed in
10% buffered formalin for 2 days before histological examination
of the site of injection.
Drug administration protocol. Drugs were applied locally by
microiontophoresis and the effect on the activity of hippocampal
neurons was recorded. Increasing ejection currents of 1, 2,
4, 8, 16 and 32 nA were used to evaluate the dose-related
effects of glutamate on the firing rate of recorded neurons, while a
continuous ejection current of quisqualate, ranging from 1 up to
3, was used to activate and maintain spontaneous firing since
hippocampal neurons are silent under general anesthesia. A re-
tention current of 10 nA was used to prevent leakage of glutamate
between ejection periods.
In a subsequent series of experiments, the effect of local
co-administration of glutamate and D-AP5 or NBQX was evalu-
ated using multi-barrel micropipettes. The local ejection of D-AP5
or NBQX antagonist was started 1 min before, and throughout the
whole period of application of increasing ejection currents of glu-
tamate. Ejection currents ranging from 2 to 5 nA were used
for these two antagonists, while a retention current of 10 nA was
used to prevent leakage between ejection periods. A continuous
ejection current of L-quisqualic acid was maintained during the
entire single unit recording.
Data analysis. Data were acquired and stored on computer
using an integrated software package for electrophysiology (RISI,
Symbolic Logic, Dallas, TX, USA). Rate histograms were dis-
played as spikes per 10-s intervals. Mean firing rate calculated
over the entire period of glutamate ejection (1 min) was used to
construct current–response curves, comparing post-injection pe-
riods to basal firing rate (percentage change).
Statistical analysis
Data are represented as meanstandard error (nnumber of
animals). Statistical significance was determined by using one-
way ANOVA followed by Fisher’s test for Western blot data or
Dunnett’s test for microdialysis data (for basal glutamate release).
One-way ANOVA for repeated measures followed by either Fish-
er’s PLSD or Dunnett’s test was used for the statistical analysis of
electrophysiological or microdialysis data (for depolarization-in-
duced glutamate release) respectively; the genotype was consid-
ered as between the subject factor and the ejecting currents
(electrophysiology) or time (microdialysis) as the within subject
factor.
RESULTS
AMPA, N-methyl-D-aspartic acid (NMDA) and kainate
receptor subunits in the hippocampus of p55/ or
p75/ mice
Fig. 1 shows the levels of AMPA (GluR2, GluR3), KA
(GluR6/7) and NMDA (NR1, NR2A/B) receptor subunits in
the total homogenate (A) and membrane (B) fractions of
hippocampi from p55/ or p75/ mice.
p55/: These mice showed an average 20% de-
crease of GluR3 and a 30% decrease of NR1 receptor
subunits in total homogenate; a 40% decrease in both
receptor subunits was found in the membrane fraction. No
differences were observed in the GluR1 (see relative
bands in Fig. 1), GluR2, GluR6/7 and NR2A/B subunits.
p75/: These mice showed an average 40% and 80%
GluR2 increase in total homogenate and membrane frac-
tion, respectively; a 40% GluR3 increase was detected
in both fractions. GluR6/7 was increased by 50% and
NR2A/B subunits were increased by 40% on average in
both fractions compared to wild-type mice. No differences
were found in GluR1 and NR1 receptor subunits.
Spontaneous and depolarization-induced glutamate
release
Microdialysis was used to measure basal and depolariza-
tion-induced glutamate release since glutamate dialysate
levels reflect extracellular glutamate concentrations. Fig.
2A depicts the basal glutamate release in p55/ and
p75/ mice vs. wild-type mice. Mice lacking p55 recep-
tors showed 50% decrease (P0.05 by one-way
ANOVA) of spontaneous glutamate outflow compared to
wild-type mice while no significant changes were found in
p75/ mice. Fig. 2B shows the effect of 60 mM KCl on
dialysate levels: no significant differences in depolariza-
tion-induced glutamate release were observed in mice
lacking p55/ or p75/ receptors.
Electrophysiological experiments
Effect of local application of glutamate. A total of 26
neurons were recorded in vivo from the hippocampus of
the three experimental groups of mice (n5–8). The quis-
qualate-induced basal firing rate of recorded neurons for
each genotype did not differ (wild-type, 7.920.9 (n5);
p55/, 11.612.9 (n8); p75/, 7.401.4 (n11);
F2,211.306, P0.2919 by one-way ANOVA). Fig. 3A, B
shows the effect of increasing currents of glutamate on the
mean firing rate of recorded neurons. Typical rate histo-
grams show the excitatory effect of microiontophoretically
applied glutamate in the three experimental groups (Fig.
3A). Mean firing rate for each current was calculated over
the ejection period (1 min) and reached a maximal in-
crease above baseline of 302.7%65.0% at 32 nA for
the p55/ group, 609.1%128.2% at 32 nA for the
p75/ group, and 233.2%67.7% at16 nA for wild-type
mice (Fig. 3B). Statistical analysis revealed an overall
significant difference between genotypes (F4,193.27,
P0.05 by one-way ANOVA for repeated measures) and
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an overall significant effect of the increasing currents of
glutamate (F5,957.73, P0.01 by one-way ANOVA for
repeated measures). Pairwise comparisons revealed a
significant difference (Fisher’s PLSD post hoc test) be-
tween p75/ versus wild type mice at the current of 16
and 32 nA (Fig. 3B).
Involvement of AMPA and NMDA receptors. We
evaluated if the effects elicited by glutamate on mean firing
rate of recorded hippocampal neurons in the p75/ mice
were mediated by AMPA and/or NMDA glutamate recep-
tors, using microiontophoretic application of the selective
NMDA receptor antagonist AP-5 or the selective AMPA
receptor blocker NBQX (Fig. 3B). A total number of six
neurons were recorded from the hippocampus of p75/
mice exposed to glutamate with either AP-5 (n3) or
NBQX (n3). AP-5 and NBQX applied individually signif-
icantly counteracted the excitation induced by microionto-
phoretically applied glutamate (F4,193.27, P0.05 by
Fig. 1. AMPA, KA and NMDA receptor subunit levels in the hippocampus of p55/ or p75/ mice. Bargrams show densitometry analysis
(meanSE, n5) of the bands corresponding to AMPA, KA and NMDA receptor subunits as assessed by Western blot analysis of hippocampal
homogenates (A) or membrane (B) fractions of wild type (WT), p55/ and p75/ mice. The optical density (O.D.) values of the relevant bands (as
depicted in the representative Western blots), are divided by the corresponding internal standard neurofilament (NF) or -tubulin. Data are expressed
as % of corresponding values in WT mice. m-Tubulin and c-tubulin represent the internal standard in the membrane (m) or cytosol (c) fractions.
* P0.05; ** P0.01 versus WT by one-way ANOVA followed by Fisher’s test.
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one-way ANOVA for repeated measures). Statistical anal-
ysis also revealed a significant interaction between the
applied currents and the experimental groups (wild type,
p75/ with/without antagonists; F20,951.97, P0.05 by
one-way ANOVA for repeated measures). Pairwise com-
parisons showed a significant difference (Fisher’s PLSD
post hoc test) in the dose–response curves between
p75/ mice treated with glutamate alone and those with
glutamate and either AP-5 or NBQX at 16 (for NBQX)
and 32 nA ejection current (for both antagonists).
DISCUSSION
The use of TNF-alpha receptors knockout mice is a valu-
able tool to study the role of p55 and p75 receptor signaling
in the physiopathological effects of this cytokine in CNS;
thus, pharmacological tools that could distinguish unequiv-
ocally between these two receptors are lacking.
This study reports the main finding of significant alter-
ations in the membrane levels of specific ionotropic gluta-
mate receptor subunits in the hippocampus of naive mice
lacking either p55 or p75 TNF-alpha receptors. The ab-
sence of TNF-alpha receptors determines modifications in
different glutamate receptor subunits, namely a decrease
in NR1 and GluR3 in p55/ mice and an upregulation of
GluR2, GluR3, GLUR6/7 and NR2AB in p75/ mice.
These differential changes support previous evidence of
a divergent signaling mediated by TNF-alpha receptor
subtypes leading to different outcomes (Sriram and
O’Callaghan, 2007).
In p75/ mice, the upregulation of AMPA GluR2 and
GluR3 and NMDA NR2A/B receptor subunits is associated
with enhanced responses of hippocampal neurons to ion-
tophoretically ejected glutamate, and this effect is blocked
by AMPA and NMDA receptor specific antagonists. It
seems therefore that the changes in GluR3 and NR2A/B
receptor subunits determine an increased neuronal excit-
ability. The upregulation of AMPA GluR2 subunit confers
low Ca2 permeability to AMPA receptors (Isaac et al.,
2007), therefore this receptor conformation cannot contrib-
ute to hyperexcitability that is associated with increased
neuronal Ca2 influx, but may rather represent a compen-
satory homeostatic change.
Kainate GluR6/7 receptor subunits are also upregu-
lated in these p75/ mice; however, we could not inves-
tigate whether their responses to glutamate was enhanced
because of the lack of selective blockers of GluR6/7-con-
taining kainate receptors (Vincent and Mulle, 2008).
In p55/ mice, we found a selective decrease in
hippocampal AMPA GluR3 and NMDA NR1 protein levels.
These receptor modifications were not associated with
altered responses of hippocampal neurons to applied glu-
tamate. A possible explanation is that there is a relatively
small number of neurons bearing the receptor subunit
changes, therefore a reduced neuronal response to gluta-
mate may be difficult to detect by single unit electrophys-
iological analysis.
We also investigated whether the deletion of p75 or
p55 receptors was associated with modifications in extra-
cellular glutamate levels under basal or depolarizing con-
ditions, using in vivomicrodialysis. We found that the basal
extracellular glutamate level was significantly reduced in
p55/ mice as compared to wild-type controls while it did
not change in p75/ mice. We speculate that the de-
crease in basal extracellular glutamate levels in p55/
mice is due to a reduction in astrocytic glutamate release
for the following reasons: (1) the basal extracellular gluta-
mate level measured by microdialysis likely reflects gluta-
mate release from astrocytes since it is insensitive to te-
trodotoxin (TTX) and has a low dependence on Ca2 (Del
Arco et al., 2003; van der Zeyden et al., 2008); (2) TNF-
alpha induces the astrocytic release of glutamate acting on
p55 receptors (Bezzi et al., 2001), thus supporting our
finding of a reduced basal glutamate release in the ab-
sence of p55 receptors.
Moreover, the lack of changes in high KCl-induced
glutamate release in both receptor knockout mice supports
the view that TNF-alpha specifically affects astrocytic, but
not depolarization-dependent neuronal glutamate release
(Bezzi et al., 2001; Del Arco et al., 2003).
The mechanism by which perturbation of p55 or p75
receptor signaling alters glutamate receptor levels remains
to be investigated and may involve transcriptional (Fu-
rukawa and Mattson, 1998; Albensi and Mattson, 2000;
MacEwen, 2002) or post-translational effects (Beattie et
Fig. 2. Spontaneous outflow and depolarization-induced glutamate release. (A) Bargrams represent meanSE (n7–8) of the basal glutamate
outflow in the hippocampus of wild type (WT), p55/ and p75/mice. * P0.05 versus WT by one-way ANOVA followed by Dunnett’s test. (B) Graph
represents the effect of 60 mM KCl on dialysate glutamate concentrations in the hippocampus of WT p55/ and p75/ mice, expressed as
percentage of basal outflow levels.
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al., 2002; Ogoshi et al., 2005). This latter possibility is
supported by previous evidence showing a role of phos-
phatidylinositol-3 kinase in TNF-alpha induced exocytosis
of AMPA receptors in hippocampal pyramidal cells, an
effect mediated by p55 receptors (Stellwagen et al., 2005).
The glutamate receptor changes we have measured in
naive p55 and p75 knockout mice are compatible with their
altered susceptibility to seizures, as reported in previous
studies where these mice were intrahippocampally in-
jected with kainic acid (Balosso et al., 2005).
In light of our present results, the increased seizure
susceptibility in p75/ mice (Balosso et al., 2005) could
be explained by at least two non-mutually exclusive mech-
anisms: (1) an enhanced response of mice to kainate upon
its intrahippocampal injection, due to the intrinsic upregu-
lation of kainate GluR6/7 subunit; accordingly, the hip-
pocampal overexpression of GluR6 predisposes to sei-
zures (Telfeian et al., 2000) while GluR6 knockout mice
are resistant to kainate seizures (Mulle et al., 1998); (2) the
intrinsic upregulation of NR2A/B and GluR3 subunits may
amplify the neuronal responses to glutamate that is re-
leased during kainate-induced epileptic activity. In partic-
ular, the upregulation of NR2A/B protein level in p75/
mice suggests the presence of an NMDA heteromeric
receptor favoring both neuronal Ca2 influx in response to
glutamate (Viviani et al., 2003) and neuronal synchroniza-
tion because of the lowest deactivation kinetics of NR2A/B
containing receptors (Cull-Candy and Leszkiewicz, 2004).
GluR3 receptor subunit also appears to be prominently
involved in ictogenesis since rodents developing GluR3
receptor-activating antibodies develop seizures (Rogers et
al., 1994; Levite and Ganor, 2008).
In p55/ naive mice, both GluR3 and NR1 receptor
subunits are decreased but no changes in the neuronal
responses to glutamate application have been observed in
these mice (see above). It seems therefore unlikely that
these GluR3 and NR1 modifications contribute significantly
to decrease p55/ mice susceptibility to kainate seizures
Fig. 3. Effect of local application of glutamate on the firing rate of hippocampal neurons. (A) Typical rate histograms showing the excitatory effect of
microiontophoretically applied glutamate in wild-type (n5), p55/ (n8), p75/ (n5) mice and its blockade by AP5 and NBQX in p75/ mice
(2 nA; n3 in each group). Numbers above each bar indicate the ejection current of glutamate in nA. The graph in B depicts current–response curves
showing the mean percentage changesSE elicited by glutamate in the various experimental groups, and the effect of AP5 and NBQX in p75/mice.
Each point represents the mean firing rate calculated over the entire ejection period. * P0.05; ** P0.01 versus wild type group; # P0.01 versus
AP-5glutamate;  P0.05 versus NBQXglutamate group by one-way ANOVA for repeated measures followed by Fisher’s PLSD test.
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(Chapman et al., 1996; Zapata et al., 1997; Balosso et al.,
2005) and other mechanisms should be considered. In
particular, recent evidence demonstrates a significant role
of astrocytic glutamate release in determining the strength
of ictal events (Fellin et al., 2006), and this release is
apparently reduced in p55/ mice (see above).
CONCLUSION
In conclusion, our study highlights novel molecular and
functional interactions between p55 and p75 receptor-me-
diated TNF-alpha signaling and the glutamate system in
the mouse hippocampus. These findings strengthen the
emerging evidence that inflammatory mediators modulate
excitatory neurotransmission (Beattie et al., 2002; Viviani
et al., 2003; Leonoudakis et al., 2004; Stellwagen et al.,
2005; Stellwagen and Malenka, 2006; Pickering and
O’Connor, 2007; Viviani et al., 2007) and suggest that
TNF-alpha and glutamate interactions may play a role in
pathological conditions (e.g. seizures, neurodegeneration)
characterized by the activation of both systems (Ferguson
et al., 2008; Vezzani and Granata, 2005).
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